Oct. 13, 2020
Clinical trials are testing whether medications that treat human immunodeficiency virus (HIV) can also treat COVID-19, leading some patients with HIV to believe they might be protected against the coronavirus. But a researcher from the University of Missouri School of Medicine not only found patients with HIV are susceptible to the virus, she also discovered which factors increased the risk of hospitalization and death.
“We were able to show that patients with HIV who are actively taking their medication are just as susceptible to COVID-19 as the general public,” said Dima Dandachi, an assistant professor of clinical medicine at the MU School of Medicine. “And those with low immunity uncontrolled HIV or newly diagnosed HIV are at a higher risk of hospitalization or death. The key message for these patients is to take precautions against contracting the virus while ensuring they are compliant with their HIV medications to raise their immune cell count as high as possible.”
Dandachi and her team of researchers found people with HIV older than 60 and those with chronic health issues also had a much higher risk of being hospitalized or dying from COVID-19.
As a researcher-clinician who treats patients with HIV, Dandachi will use this study to counsel her patients to best protect themselves against COVID-19 while also using it as proof that this patient population should be among the first considered for protection once a vaccine is developed.
How much are CEOs really making?
Study finds firms could be misleading investors about executive pay.
Study reveals risk factors for acute kidney injury after brain hemorrhage
Knowing which patients are at the highest risk can help doctors take precautions to prevent a severe kidney injury.
Journalism scholar team finds early foreign correspondents often came from socially less advantaged groups
This research reminds the news industry that having more journalists from a wider range of backgrounds can help to broaden the perspectives and issues addressed in international news.
Novel dashboard improves cancer case review efficiency
Dashboard enables easy access to clinical data, reduces costs for patients and hospitals and supports optimal decision-making.
Stay up-to-date on all things Mizzou when you subscribe to the Show Me Mizzou newsletter. Issues will arrive in your inbox every Tuesday, Wednesday and Thursday.